Cases We Accept

Blog

Defective Products & Liability

View All

Latest News

View All

Library

Defective Products & Liability

View All

Case Results

$ 3.5 million Settlement for
auto injury

Our eighteen-year-old client was driving on an interstate into the early morning sun. As he drove over a rise in the road, he struck a car that was disabled and stopped in the middle of the road because a 150-pound wheel and tire detached from a tractor-trailer rig traveling in the opposite direction. The lugs holding the tire had broken off, causing the tire and wheel to travel across the median strip, and hit and disable the stopped vehicle.
Awarded: $ 3.5 million

$1,000,000 Jury Verdict for
86 year-old woman

Our client an 86 year-old woman sustained an injury after being struck by a bus. The inattentive bus driver was warned by a passenger that the woman was crossing in front of the bus but could not stop in time to avoid impact.
Awarded: $1,000,000

$785,000 Settlement for
crushed ankle

Our client was operating his motorcycle on a two-lane road when a large box truck made a U-turn into his path of travel. The client attempted to avoid the collision by laying his motorcycle on its side. Unfortunately his lower leg and ankle came in contact with the truck causing seven fractures and soft tissue injury.
Awarded: $785,000

DISCLAIMER: Please note that every case is different and these verdicts and settlements, while accurate, do not represent what we may obtain for you in your case.

Latest News

Eli Lilly Agrees to $1.4 Billion Settlement in Zyprexa Probes

Posted on Jan 26, 2009

Eli Lilly and Co. has announced that it will pay approximately $1.4 billion to settle criminal and civil investigations into the marketing of its antipsychotic drug Zyprexa and has agreed to plead guilty to a federal misdemeanor.

Lilly will pay $615 million to settle the criminal investigation and approximately $800 million to settle the civil probes initiated by State Medicaid units.

The misdemeanor charges in which Lilly agreed to plead guilty stemmed from the advertisement of Zyprexa as a treatment for ailments that it was not approved between September 1999 and March 2001, a practice known as off-label promotion.

"Specifically, the plea states that Lilly promoted Zyprexa in elderly populations as treatment for dementia, including Alzheimer's dementia, although Zyprexa is not approved for such uses," Lilly said in a statement.

In the third quarter of 2008, Lilly anticipated the settlement booking $1.48 billion in charges related to the investigations.

Zyprexa is one the Lilly’s biggest selling drugs and had $4.8 billion in sales in 2007. This drug is commonly used as atypical antipsychotics to treat schizophrenia. However, Zyprexa also appears to carry side effects, such as weight gain, which can lead to diabetes.

"Eli Lilly had an army of 2,000 sales representatives engaged in nothing but off-label marketing," said Laurie Magid, the Acting U.S. Attorney in Philadelphia in an interview.

Nursing homes and assisted living facilities were targeted by one Lilly sales force, despite the fact that schizophrenia is rare among the elderly. During the visits to the nursing homes, Lilly sales reps promoted weight gain from Zyprexa as a health-promoting benefit, instead of a troublesome side effect.

In 2011, Zyprexa is supposed to lose patent protection. U.S. regulators have delayed their final decision regarding the approval of a long-acting form of the drug.

Lilly has also agreed to enter into a corporate integrity agreement with the Office of Inspector General of the U.S. Department of Health and Human Services.

Share |

Need Help Now?

Kiley Law Group
342 North Main Street
P.O. Box 3040
Andover, MA 01810
Phone: 978-474-8670
Fax: 978.474.8946
Toll Free: 800-410-2769

Get Directions